The World Health Organization (WHO) said on Friday that it had had a very good dialogue with the developers of a second Russian candidate vaccine against COVID-19. “We can only have a position on a vaccine when we see the results of phase III clinical trials,” said WHO chief scientist …
Read More »Russia ready to approve second vaccine next week
Russia is set to register its second coronavirus vaccine on October 15, the vaccine developer said on Friday, according to a Reuters report. Developed by Vector’s State Research Center for Virology and Biotechnology, the experimental vaccine has recently completed its early-stage human trials. “The Ministry of Health of the Russian …
Read More »1.2 billion doses of Russian vaccine reserved
By: Desk Explained | Pune | Updated: September 22, 2020 9:16:23 am Moscow: An injection of Russia’s experimental Sputnik V coronavirus vaccine is shown before use in Moscow, Russia (AP) Coronavirus Vaccine Tracker: At least ten countries in Asia, South America and the Middle East have signed agreements to access …
Read More »1 in 7 volunteers for Sputnik V, the side effects of Russia’s Covid-19 vaccine report: Russian minister
One in seven volunteers complained of side effects after being injected with Sputnik V, Russia’s experimental vaccine against the coronavirus disease (Covid-19), the country’s health minister said. Mikhail Murashko, the Russian health minister, said that more than 300 of the 40,000 announced volunteers have been vaccinated with Sputnik V so …
Read More »Russia to sell 100 million doses of Sputnik-V vaccine to Dr. Reddy’s lab
Russia Sputnik-V vaccine: 100 million doses of Sputnik-V vaccine to be sold to India (Representative) Moscow: Russia’s sovereign wealth fund has agreed to supply 100 million doses of its coronavirus vaccine, Sputnik-V, to Indian pharmaceutical company Dr Reddy’s Laboratories, the fund said on Wednesday, as Moscow accelerates plans to distribute …
Read More »Oxford University, Pfizer, Modern, Russia, Bharat Biotech Covaxin
Written by Abhishek De | New Delhi | Updated: September 7, 2020 9:27:45 pm According to the World Health Organization, about 175 vaccine candidates are in preclinical or clinical trials today. While Russia and China may have stolen a march in the race to develop a Covid-19 vaccine, grant regulatory …
Read More »Russia Shares Vaccine Data With India, One Option Is Phase 3 Trials Here
Written by Kaunain Sheriff M | New Delhi | Updated: September 7, 2020 6:56:29 am The candidate vaccine elicited a “strong” immune response in Phases 1 and 2 of clinical trials in 76 people. (AP Photo) Even when the Lancet published the data from the phase 1 and phase 2 …
Read More »Reading Results of Russia’s Covid-19 Vaccine Trial
Written by Anuradha Mascarenhas | Pune | Updated: September 5, 2020 8:08:10 am The vaccine is the first in the world licensed for general use. (Photo: AP) The much-criticized Russian vaccine against the novel coronavirus was found to be safe and also triggered a “strong” immune response, according to results …
Read More »Russia’s Coronavirus Vaccine ‘Safe’, Passes Preliminary Test: Lancet Study
Russia COVID-19 Vaccine: Russia’s vaccine is called “Sputnik V” and has received approval. London: Patients who participated in the first trials of a Russian coronavirus vaccine developed antibodies without “serious adverse effects,” according to research published in The Lancet on Friday, but experts said the trials were too small to …
Read More »Russia’s covid vaccine produces immune response, has no side effects – peer review
Russia’s proposed Covid-19 vaccine induced an antibody response in all participants in the early trials and found no serious adverse effects, according to early peer-reviewed data on studies from the controversial project. The vaccine also produced a response in T cells, a type of white blood cell that helps the …
Read More »